15 Biggest Mid-Day Gainers For Monday

Loading...
Loading...
  • Cyclacel Pharmaceuticals Inc CYCC shares surged 51 percent to $5.17. Cyclacel announced the presentation demonstrating therapeutic potential of CYC065 in lung cancer at the AACR 2017.
  • Novocure Ltd NVCR shares climbed 46 percent to $11.82 after the company disclosed that the two-year survival rate for GBM Patients increased from 30% to 43% for patients treated with Optune + temozolomide versus temozolomide alone at the AACR 2017.
  • Steadymed Ltd STDY shares surged 38.4 percent to $8.10. Cardiome's partner SteadyMed received a favorable ruling in USPTO Inter Partes Review in validity of U.S. Patent No. 8,497,393.
  • Polarityte Inc COOL shares rose 31 percent to $17.90.
  • China Auto Logistics Inc CALI shares surged 17 percent to $1.77.
  • GEE Group Inc JOB gained 15.5 percent to $5.65. GEE Group has acquired SNI Companies through merger.
  • Professional Diversity Network Inc IPDN climbed 12.1 percent to $10.75. Professional Diversity Network reported a FY16 loss of $1.98 per share on revenue of $26.23 million.
  • AirMedia Group Inc (ADR) AMCN shares jumped 10.6 percent to $3.04.
  • Matinas BioPharma Holdings Inc MTNB rose 8.3 percent to $3.00 in pre-market trading. Matinas BioPharma reported a FY16 loss of $0.21 per share.
  • Cellect Biotechnology Ltd. APOP rose 7.2 percent to $9.22 after the company reported an European patent grant.
  • Eleven Biotherapeutics Inc EBIO rose 6.8 percent to $2.35. Eleven Biotherapeutics presented new preclinical data supporting potential of the company's locally and systematically-administered drug candidates at the AACR 2017.
  • Kite Pharma Inc KITE climbed 5.6 percent to $82.86. Kite presented ongoing response rate in plenary session from its pivotal CAR-T trial of Axicabtagene Ciloleucel in patients with aggressive non-hodgkin lymphoma at AACR 2017.
  • Syneron Medical Ltd. ELOS shares gained 5.3 percent to $11.11. Syneron Candela agreed to be acquired by funds advised by Apax Partners for $11 per share in cash.
  • Infinity Pharmaceuticals Inc. INFI rose 5 percent to $3.39. Infinity Pharmaceuticals presented updated Phase 1 data for IPI-549 at the AACR 2017.
  • Loxo Oncology Inc LOXO gained 4.7 percent to $44.05. Morgan Stanley initiated coverage on Loxo Oncology with an Overweight rating.
Loading...
Loading...
Posted In: NewsIntraday UpdateMarketsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...